Monopar Therapeutics, Inc. (MNPR)
55.13
-0.26
(-0.47%)
USD |
NASDAQ |
Apr 02, 16:00
55.33
+0.20
(+0.36%)
After-Hours: 20:00
Monopar Therapeutics Market Cap : 368.54M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 22.33M |
| BioStem Technologies, Inc. | 84.11M |
| Iovance Biotherapeutics, Inc. | 1.403B |
| Protokinetix, Inc. | 2.482M |
| GB Sciences, Inc. | 0.1221M |
Market Cap Related Metrics
| Price to Book Value | 2.677 |
| Price | 55.13 |
| Earnings Yield | -3.60% |